n-acetylcysteinamide has been researched along with Bronchial Hyperreactivity in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atlas, D; Choe, YH; Han, HJ; Hong, SH; Kim, JS; Kim, SR; Lee, KS; Lee, KY; Lee, YC; Lee, YR; Min, KH; Park, HS; Park, SJ | 1 |
1 other study(ies) available for n-acetylcysteinamide and Bronchial Hyperreactivity
Article | Year |
---|---|
A novel thiol compound, N-acetylcysteine amide, attenuates allergic airway disease by regulating activation of NF-kappaB and hypoxia-inducible factor-1alpha.
Topics: Acetylcysteine; Animals; Asthma; Bronchial Hyperreactivity; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; NF-kappa B; Ovalbumin; Reactive Oxygen Species; Vascular Endothelial Growth Factor A | 2007 |